Get the Stockscreener App
0.0915
22.98%
-0.0273
After Hours:
.09
-0.0015
-1.64%
Aditxt Inc Stock (ADTX) Latest News
Aditxt subsidiary Persanta engages Dominary Securities for IPO - TipRanks
Aditxt Co's Unit Pearsanta Engaged Dominari Securities Llc As Lead Underwriter For Pearsanta's Planned IPO - Marketscreener.com
Aditxt subsidiary Pearsanta prepares for IPO with lead underwriter By Investing.com - Investing.com South Africa
Aditxt, Inc Subsidiary Pearsanta Engages Dominari Securities for its IPO By Investing.com - Investing.com South Africa
Aditxt, Inc Subsidiary Pearsanta Engages Dominari Securities for its IPO - Investing.com India
Aditxt subsidiary Pearsanta prepares for IPO with lead underwriter - Investing.com
Can This New DNA Cancer Test Disrupt the $20B Diagnostics Market? Pearsanta Unveils IPO Plans - StockTitan
Microcap Biotech Aditxt Rallies Retail Interest Ahead Of CEO’s Fireside Chat: What’s On Investors’ Radar? - MSN
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
ADTX Stock Earnings: Aditxt Reported Results for Q1 2024 - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga India
Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket - Benzinga
Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Decline in Short Interest - Defense World
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 - TradingView
Appili Q3 Earnings: Pipeline Success With $14M Funding, FDA Progress, and Take-Private Deal | APLIF Stock News - StockTitan
ADTX stock plunges to 52-week low, touches $0.07 By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
ADTX stock plunges to 52-week low, touches $0.07 - Investing.com
Inside Aditxt's Pipeline: CEO Reveals Latest on Type 1 Diabetes Treatment and Cancer Detection Program - StockTitan
Metric Deep Dive: Understanding Aditxt Inc (ADTX) Through its Ratios - The Dwinnex
A stock that deserves closer examination: Aditxt Inc (ADTX) - US Post News
Market cap of Aditxt Inc [ADTX] reaches 7.10M – now what? - The DBT News
Aditxt Inc (ADTX) Stock: A Look at the Analyst Recommendations - The News Heater
Understanding the Risks of Investing in Aditxt Inc (ADTX) - Knox Daily
Aditxt Inc (NASDAQ: ADTX) Could Pass $160 In One Year Stock Forecast - Stocks Register
ADTX’s Market Whiplash: -42.04% YTD Decline, -42.04% Plunge in 30 Days - The InvestChronicle
Aditxt, Inc. (NASDAQ:ADTX) Sees Large Growth in Short Interest - Defense World
Aditx Therapeutics stock hits 52-week low at $0.12 By Investing.com - Investing.com Australia
Aditx Therapeutics stock hits 52-week low at $0.12 - MSN
Aditxt (NASDAQ: ADTX) Board Considers IPO for Subsidiary PearsantaMountain View, CA – January 13, 2025 – Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”) announced today that its Board of Directors has given the green light for exploring the p - Defense World
Aditxt explores IPO for subsidiary Pearsanta in 2025 By Investing.com - Investing.com Canada
Aditxt explores IPO for subsidiary Pearsanta in 2025 - Investing.com India
Aditxt, Inc. Plans IPO for Pearsanta in 2025 - TipRanks
Aditxt's Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform - Quantisnow
Aditx Therapeutics stock hits 52-week low at $0.17 By Investing.com - Investing.com Australia
Aditx Therapeutics stock hits 52-week low at $0.17 - Investing.com
ADTX Stock on the Rise: A Promising Investment - The InvestChronicle
Shares Of Aditxt Inc (NASDAQ: ADTX): Are They Overvalued Compared To Others? - Stocks Register
Aditxt Inc (NASDAQ: ADTX) Inclines 3.78%: This $2.72 million Stock Could Go Down -79900.0% - Stocks Register
Perspective Therapeutics Inc (AMEX: CATX) Could Fell Another -684.31% - Stocks Register
Devon Energy Corp (NYSE: DVN) Stock Forecast: Could Pass $55 In A Year - Stocks Register
No Stopping Energy Transfer LP (NYSE: ET)’s Stock Surged? - Stocks Register
Aditxt, Inc. (NASDAQ:ADTX) Short Interest Down 45.2% in December - Defense World
ADTX stock plunges to 52-week low, touches $0.18 By Investing.com - Investing.com Nigeria
ADTX stock plunges to 52-week low, touches $0.18 - Investing.com
Aditx Therapeutics stock hits 52-week low at $0.31 By Investing.com - Investing.com Canada
Aditx Therapeutics stock hits 52-week low at $0.31 - Investing.com
Aditxt, Inc. (NASDAQ:ADTX) Sees Large Decrease in Short Interest - Defense World
Aditxt Advances ADI-100 Therapy to Human Trials - TipRanks
Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials - Quantisnow
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):